Bios Capital Management, Lp
- Regulatory AUM
- $251M
- Discretionary
- $251M
- Clients
- 24
- Avg AUM / client
- $10.5M
- Accounts
- 24
- Employees
- 8
AUM over time
Reported AUM from Form ADV filings, plotted by filing date · as of Mar 30, 2026
Who they serve
| Client type | Clients | AUM | % of AUM |
|---|---|---|---|
| Pooled investment vehicles (non-investment companies) | 24 | $251M | 100.0% |
Private funds (25)
View all →Reported in Form ADV Section 7.B.(1), filing of Mar 2024 · $278M combined gross assets
| Fund | Type | Domicile | Gross assets | Owners |
|---|---|---|---|---|
| Bios Fund Iii Qp, Lp | Venture Capital Fund | Texas | $86.4M | 305 |
| Bios Fund Ii Qp, Lp | Venture Capital Fund | Texas | $27.4M | 112 |
| Bios Special Opportunity Fund, Lp | Private Equity Fund | Texas | $16.5M | 74 |
| Bios Actuate Co Invest Ii, Lp | Venture Capital Fund | Texas | $16.4M | 94 |
| Bios Fund Iii Nt, Lp | Venture Capital Fund | Texas | $14.6M | 20 |
| Bios Fund Iii, Lp | Venture Capital Fund | Texas | $12.7M | 92 |
| Bios Fund I, Lp | Venture Capital Fund | Texas | $11.3M | 89 |
| Bios Lti Co Invest Iii Qp, Lp | Venture Capital Fund | Texas | $10.8M | 30 |
| Bios Lti Co Invest Iii, Lp | Venture Capital Fund | Texas | $10.5M | 100 |
| Bios Onl Co Invest I, Lp | Venture Capital Fund | Texas | $9.7M | 83 |
| Bios Clinical Opportunity Fund, Lp | Venture Capital Fund | Texas | $9.3M | 29 |
| Bios Fund Ii, Lp | Venture Capital Fund | Texas | $8.4M | 86 |
| Bios Fund I Qp, Lp | Venture Capital Fund | Texas | $6.6M | 33 |
| Bios Sirpant Co Invest I, Lp | Venture Capital Fund | Texas | $5.4M | 95 |
| Bios Sirpant Co Invest I Qp, Lp | Venture Capital Fund | Texas | $5.4M | 35 |
People (1)
roster as of Jul 20, 2026| Name | Role / title | Credentials | With firm since | Ownership |
|---|---|---|---|---|
| Aaron Glenn Louis Fletcher | Limited Partner, Chief Compliance Officer | Jun 2013 (13y) | 75% or more |
Entity owners (Schedule A/B)
| Entity | Title / status | Since | Sch. | Ownership |
|---|---|---|---|---|
| Bios Advisors Gp, Llc | General Partner | Jun 2013 | A | Less than 5% |
Undisclosed: 0% – 25% of the firm is not attributable from the filed Schedule A bands.
Roster from the IAPD representatives feed; ownership and acquisition dates from Form ADV Schedule A/B. "Since" is the earliest filed registration or acquisition date.
Private funds (25, $278M gross assets)
| Fund | Type | Gross assets | Min. investment | Owners |
|---|---|---|---|---|
| Bios Fund Iii Qp, Lp | Venture Capital Fund | $86.4M | $200K | 305 |
| Bios Fund Ii Qp, Lp | Venture Capital Fund | $27.4M | $8.0K | 112 |
| Bios Special Opportunity Fund, Lp | Private Equity Fund | $16.5M | $1.0M | 74 |
| Bios Actuate Co Invest Ii, Lp | Venture Capital Fund | $16.4M | $20.0K | 94 |
| Bios Fund Iii Nt, Lp | Venture Capital Fund | $14.6M | $200K | 20 |
| Bios Fund Iii, Lp | Venture Capital Fund | $12.7M | $200K | 92 |
| Bios Fund I, Lp | Venture Capital Fund | $11.3M | $5.0K | 89 |
| Bios Lti Co Invest Iii Qp, Lp | Venture Capital Fund | $10.8M | $20.0K | 30 |
| Bios Lti Co Invest Iii, Lp | Venture Capital Fund | $10.5M | $20.0K | 100 |
| Bios Onl Co Invest I, Lp | Venture Capital Fund | $9.7M | $20.0K | 83 |
| Bios Clinical Opportunity Fund, Lp | Venture Capital Fund | $9.3M | $20.0K | 29 |
| Bios Fund Ii, Lp | Venture Capital Fund | $8.4M | $8.0K | 86 |
| Bios Fund I Qp, Lp | Venture Capital Fund | $6.6M | $20.0K | 33 |
| Bios Sirpant Co Invest I, Lp | Venture Capital Fund | $5.4M | $10.0K | 95 |
| Bios Sirpant Co Invest I Qp, Lp | Venture Capital Fund | $5.4M | $10.0K | 35 |
| Bios Actuate Co Invest Iii, Lp | Venture Capital Fund | $4.8M | $20.0K | 21 |
| Bios Special Opportunity Fund Ii, Lp | Private Equity Fund | $4.0M | $1.0M | 20 |
| Bios Lti Spv Ii, Lp | Venture Capital Fund | $3.7M | $3.5K | 49 |
| Bios Fund Ii Nt, Lp | Venture Capital Fund | $3.7M | $20.0K | 19 |
| Bios Memory Spv I, Lp | Venture Capital Fund | $2.6M | $1.0K | 42 |
| Bios Immusoft Co Invest I, Lp | Venture Capital Fund | $2.4M | $20.0K | 51 |
| Bios Actuate Co Invest I, Lp | Venture Capital Fund | $2.4M | $20.0K | 41 |
| Bios Incycus Co Invest I, Lp | Venture Capital Fund | $1.4M | $1.0K | 63 |
| Bios Memory Spv Ii, Lp | Venture Capital Fund | $713K | $2.5K | 30 |
| Bios Azitra Co Invest I, Lp | Venture Capital Fund | $413K | $20.0K | 43 |
From Form ADV Section 7.B private fund reporting.
Documents (1 archived)
| Form | Period | Size | |
|---|---|---|---|
| Form ADV (full filing) | 03/30/2026 | 5.78 MB | View · PDF · Source ↗ |
Archived copies of the firm's regulatory filings, versioned by content hash.
Disciplinary disclosures
No disciplinary events reported on the firm's latest Form ADV filing.
How they charge
- • Percentage of assets under management
- • Performance-based fees
Services
- • Portfolio management for pooled investment vehicles
Custody
Firm reports having custody of client funds or securities (Item 9.A).
No custodian data reported or mined yet.
Source
All data on this page comes from this firm's Form ADV filings, reproduced without modification. Latest filing: Mar 30, 2026.
View current Form ADV (SEC/IAPD) ↗